IRF2BP2 has been reported to be involved in the malignancy of breast cancer, leukaemia and chondrosarcoma.11, 12, 37 The TCGA database revealed that the IRF2BP2 gene was amplified in most tumours, including GC. Here, IRF2BP2 is linked to leukemia.